| HOME >> BIOLOGY >> TECHNOLOGY |
Other Receivables, net (1,247,729) (518,729)
Advances to Suppliers (273,630) 85,904
Prepaid Expense -- (4,374)
Accounts Payable and
Accrued Expenses 1,484,826 (77,148)
Deposit Received 120
Taxes Payable 414,009 58,074
Due from Related Parties (954,735)
Due to Related Parties 1,626,548 (225,171)
Other Payables 85,783 (1,391,508)
Total Adjustments (20,332,366) (8,093,669)
Net Cash Used in Operating
Activities (8,119,164) (3,569,434)
CASH FLOWS FROM INVESTING
ACTIVITIES
Acquisition of Property and
Equipment (3,493,192) (96,165)
Additions to Intangible
Assets (122,899)
Net Cash Used in Investing
Activities (3,616,091) (96,165)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Bank Loans 205,028 4,251,841
Proceeds from Share Capital 19,135,151
Proceeds from Shareholder Loans -- 831,157
Repayment of Long-term Loans -- (6,500)
Payment for Stock Issuance Costs (1,146,159) --
Net Cash From Financing Activities 18,194,020 5,076,498
EFFECT OF FOREIGN CURRENCY
TRANSLATION ON CASH 380,656 (32,791)
NET INCREASE IN CASH AND CASH
'/>"/>
| SOURCE Yongye Biotechnology International, Inc. Copyright©2008 PR Newswire. All rights reserved |